Multiple Myeloma Treatment Evolution in Transplant-Ineligible Patients

In part six of the Myeloma Series, a historical perspective on the treatment evolution of myeloma and a discussion on treating transplant-ineligible patients with multiple myeloma.

Questions investigated in this podcast episode include the following:

• How has the treatment evolved in transplant ineligible patients?
• Why is triplet regimen the standard of care in transplant ineligible patients?
• What is the trial that led to quadruplet therapy?
• What is the MAIA trial?